These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5469942)

  • 1. [Purification and concentration of antitoxic sera].
    Sezginman N; Demirtaş N
    Turk Hij Tecr Biyol Derg (1961); 1970; 30(1):63-75. PubMed ID: 5469942
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and characterization of antitoxic proteins from the serum of Agkistrodon halys Pallas.
    Niu YP; Shao JY; Jiang YL
    Toxicon; 2007 Sep; 50(3):322-9. PubMed ID: 17512568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Constituents of Amanita phalloides. XXXIX. Isolation and characterization of an antitoxic cyclopeptide, antamanid from the lipophilic fraction].
    Wieland T; Lüben G; Ottenheym M
    Justus Liebigs Ann Chem; 1969 May; 722():173-8. PubMed ID: 5817582
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of DEAE-sephadex A-50 for additional purification of antitoxic sera.
    Hristova G
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Jul; 135(5):439-48. PubMed ID: 4233694
    [No Abstract]   [Full Text] [Related]  

  • 5. [Azo-binding of antitoxic immune sera. III. Azo-proteins].
    ZIMMERMANN G
    Z Immun exp ther; 1958 Sep; 116(3):219-27. PubMed ID: 13604524
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on tetanus antitoxins. II. Demonstration of at least four antitoxins of different specificity in antitoxic sera.
    Nagel J; Cohen H
    J Immunol; 1973 May; 110(5):1388-95. PubMed ID: 4633299
    [No Abstract]   [Full Text] [Related]  

  • 7. Preparation of antibacterial and antitoxic Clostridium difficile sera.
    Sokół-Leszczyńska B; Martirossian G; Meisel-Mikołajczyk F; Mierzejewski J; Matras J; Lipnicki D; Sadowski W
    Acta Microbiol Pol; 1991; 40(3-4):153-8. PubMed ID: 1726616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution, evaluation, duration and renewal of antitoxic immunity. 2d note. Loss of antibodies].
    Nicol L
    Bull Acad Natl Med; 1970 Jun; 154(19):447-53. PubMed ID: 4916880
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of study of the antigenic properties of cell components of C1. perfringens by agar gel precipitation and immunoelectrophoresis. II. Results with the use of "monospecific" antitoxic sera.
    Rusinko M; Mikulková V; Ciznár I
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):321-6. PubMed ID: 4288097
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of the presence of cl. perfringens in the feces and of alpha antitoxins in the serum of patients with rheumatoid arthritis (author's transl)].
    Jajić I; Udovicić I; Bilić I; Jakovina M
    Lijec Vjesn; 1977 Jul; 99(7):405-8. PubMed ID: 197360
    [No Abstract]   [Full Text] [Related]  

  • 11. [Obtaining the homologous hyperimmune preparations from the blood of immunized donors - anti-coli (anti-Escherichia) and antitoxic antipyocyanotic plasma].
    Skurkovich SV; Likhoded VG; Krokhina MA; Temper RM; Demidova NV
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):51-3. PubMed ID: 417340
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitoxic immunity against the so-called lung toxin produced by Escherichia coli.
    Emödy L; Kétyi I; Kuch B; Pácsa S
    Acta Microbiol Acad Sci Hung; 1979; 26(3):233-9. PubMed ID: 396766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on Clostridium botulinum type F. II. Isolation of highly active toxin and its properties].
    Rymkiewicz D
    Med Dosw Mikrobiol; 1968; 20(3):281-7. PubMed ID: 4884893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasmapheresis as a method of obtaining donors' antistaphylococcal plasma].
    Konstantinov VN
    Sov Med; 1978 May; (5):99-103. PubMed ID: 675328
    [No Abstract]   [Full Text] [Related]  

  • 15. [Purification and enzymatic disantigenization of antitoxic serums and plasmas. III. Theoretical evaluation of antitoxic and anaphylactic function of antitoxic serums and plasmas].
    CORDON F; MARTINEZ A
    Microbiol Esp; 1957; 10(1):69-98. PubMed ID: 13464448
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preparation and evaluation of a standard botulinum A antitoxin and a botulinum A test toxin].
    Windler D; Patzwaldt HG; Friedemann J
    Pharmazie; 1971 May; 26(5):306-8. PubMed ID: 4935133
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Antitoxic effect of milk?].
    Weichardt H
    Dtsch Med Wochenschr; 1975 Jun; 100(24):1360. PubMed ID: 1173361
    [No Abstract]   [Full Text] [Related]  

  • 18. [On enhancement of antitoxic immunity under the influence of addition of saponin to staphylococcal anatoxin].
    RICHOU R; JENSEN R; BELIN C
    C R Hebd Seances Acad Sci; 1963 Jul; 257():315-7. PubMed ID: 13982180
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antitoxic effect of proteolytic enzymes used in surgery].
    Gostishev VK; Muliaev LF; Kolker II
    Eksp Khir Anesteziol; 1975; (3):50-3. PubMed ID: 1183394
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antitoxic and pyrogenic properties of rabbit polymorphonuclear leukocytes].
    Pigarevskiĭ VE; Il'in GI; Sorokin AV
    Biull Eksp Biol Med; 1968 Aug; 66(8):81-5. PubMed ID: 5758507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.